Masimo (MASI)
(Delayed Data from NSDQ)
$140.62 USD
-1.37 (-0.96%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $140.78 +0.16 (0.11%) 7:14 PM ET
2-Buy of 5 2
C Value A Growth C Momentum B VGM
Price, Consensus and EPS Surprise
MASI 140.62 -1.37(-0.96%)
Will MASI be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for MASI based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for MASI
Here's Why You Should Add Masimo Stock to Your Portfolio Now
Reasons to Retain DexCom Stock in Your Portfolio for Now
MASI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Momentum Stocks to Buy for October 1st
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Masimo (MASI) Surges 8.7%: Is This an Indication of Further Gains?
Other News for MASI
Top 2 Health Care Stocks That Are Ticking Portfolio Bombs
Analysts Have Conflicting Sentiments on These Healthcare Companies: Masimo (MASI), Baxter International (BAX) and Merck & Company (MRK)
Masimo Corp (MASI) Trading Down 3.77% on Oct 7
A Look Into Masimo Inc's Price Over Earnings
Apple rethinking approach to headsets, Bloomberg reports